View in EDS

Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial.

Saved in:
Bibliographic Details
Title: Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial.
Authors: Poh XY; National Centre for Infectious Diseases, Singapore., Torres-Ruesta A; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Yoong T; National Centre for Infectious Diseases, Singapore., Wong N; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Tan CW; Duke-NUS Medical School, Singapore., Rouers A; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Chavatte JM; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore., Goh YS; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Rao S; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore., Chia PY; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore., Ong SWX; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore., Lee TH; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore., Sadarangani SP; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore., Lin RJH; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore., Neo V; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Kam IKJ; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Huang Y; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Hor PX; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Loh CY; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Yeoh AY; Duke-NUS Medical School, Singapore., Lim DRX; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore., Chia W; Duke-NUS Medical School, Singapore., Ren EC; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Singapore Immunology Network, Agency for Science Technology and Research (A*STAR), Singapore., Lin RTP; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore., Fong SW; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Renia L; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; School of Biological Sciences, Nanyang Technological University, Singapore., Lye DC; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Wang LF; Duke-NUS Medical School, Singapore., Ng LFP; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, UK; National Institute of Health Research, Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, UK. Electronic address: lisa_ng@IDLabs.a-star.edu.sg., Young BE; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore. Electronic address: Barnaby_young@ncid.sg.
Corporate Authors: PRIBIVAC study group; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.
Source: Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126275. Date of Electronic Publication: 2024 Sep 05.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39241318
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Poh+XY%22">Poh XY</searchLink>; National Centre for Infectious Diseases, Singapore.<br /><searchLink fieldCode="AU" term="%22Torres-Ruesta+A%22">Torres-Ruesta A</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Yoong+T%22">Yoong T</searchLink>; National Centre for Infectious Diseases, Singapore.<br /><searchLink fieldCode="AU" term="%22Wong+N%22">Wong N</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+CW%22">Tan CW</searchLink>; Duke-NUS Medical School, Singapore.<br /><searchLink fieldCode="AU" term="%22Rouers+A%22">Rouers A</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Chavatte+JM%22">Chavatte JM</searchLink>; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore.<br /><searchLink fieldCode="AU" term="%22Goh+YS%22">Goh YS</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Rao+S%22">Rao S</searchLink>; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore.<br /><searchLink fieldCode="AU" term="%22Chia+PY%22">Chia PY</searchLink>; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.<br /><searchLink fieldCode="AU" term="%22Ong+SWX%22">Ong SWX</searchLink>; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+TH%22">Lee TH</searchLink>; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore.<br /><searchLink fieldCode="AU" term="%22Sadarangani+SP%22">Sadarangani SP</searchLink>; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.<br /><searchLink fieldCode="AU" term="%22Lin+RJH%22">Lin RJH</searchLink>; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore.<br /><searchLink fieldCode="AU" term="%22Neo+V%22">Neo V</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Kam+IKJ%22">Kam IKJ</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Huang+Y%22">Huang Y</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Hor+PX%22">Hor PX</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Loh+CY%22">Loh CY</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Yeoh+AY%22">Yeoh AY</searchLink>; Duke-NUS Medical School, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+DRX%22">Lim DRX</searchLink>; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore.<br /><searchLink fieldCode="AU" term="%22Chia+W%22">Chia W</searchLink>; Duke-NUS Medical School, Singapore.<br /><searchLink fieldCode="AU" term="%22Ren+EC%22">Ren EC</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Singapore Immunology Network, Agency for Science Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Lin+RTP%22">Lin RTP</searchLink>; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore.<br /><searchLink fieldCode="AU" term="%22Fong+SW%22">Fong SW</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Renia+L%22">Renia L</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; School of Biological Sciences, Nanyang Technological University, Singapore.<br /><searchLink fieldCode="AU" term="%22Lye+DC%22">Lye DC</searchLink>; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Wang+LF%22">Wang LF</searchLink>; Duke-NUS Medical School, Singapore.<br /><searchLink fieldCode="AU" term="%22Ng+LFP%22">Ng LFP</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, UK; National Institute of Health Research, Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, UK. Electronic address: lisa_ng@IDLabs.a-star.edu.sg.<br /><searchLink fieldCode="AU" term="%22Young+BE%22">Young BE</searchLink>; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore. Electronic address: Barnaby_young@ncid.sg.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PRIBIVAC+study+group%22">PRIBIVAC study group</searchLink>; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126275. <i>Date of Electronic Publication: </i>2024 Sep 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39241318
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.vaccine.2024.126275
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 126275
    Titles:
      – TitleFull: Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Poh XY
      – PersonEntity:
          Name:
            NameFull: Torres-Ruesta A
      – PersonEntity:
          Name:
            NameFull: Yoong T
      – PersonEntity:
          Name:
            NameFull: Wong N
      – PersonEntity:
          Name:
            NameFull: Tan CW
      – PersonEntity:
          Name:
            NameFull: Rouers A
      – PersonEntity:
          Name:
            NameFull: Chavatte JM
      – PersonEntity:
          Name:
            NameFull: Goh YS
      – PersonEntity:
          Name:
            NameFull: Rao S
      – PersonEntity:
          Name:
            NameFull: Chia PY
      – PersonEntity:
          Name:
            NameFull: Ong SWX
      – PersonEntity:
          Name:
            NameFull: Lee TH
      – PersonEntity:
          Name:
            NameFull: Sadarangani SP
      – PersonEntity:
          Name:
            NameFull: Lin RJH
      – PersonEntity:
          Name:
            NameFull: Neo V
      – PersonEntity:
          Name:
            NameFull: Kam IKJ
      – PersonEntity:
          Name:
            NameFull: Huang Y
      – PersonEntity:
          Name:
            NameFull: Hor PX
      – PersonEntity:
          Name:
            NameFull: Loh CY
      – PersonEntity:
          Name:
            NameFull: Yeoh AY
      – PersonEntity:
          Name:
            NameFull: Lim DRX
      – PersonEntity:
          Name:
            NameFull: Chia W
      – PersonEntity:
          Name:
            NameFull: Ren EC
      – PersonEntity:
          Name:
            NameFull: Lin RTP
      – PersonEntity:
          Name:
            NameFull: Fong SW
      – PersonEntity:
          Name:
            NameFull: Renia L
      – PersonEntity:
          Name:
            NameFull: Lye DC
      – PersonEntity:
          Name:
            NameFull: Wang LF
      – PersonEntity:
          Name:
            NameFull: Ng LFP
      – PersonEntity:
          Name:
            NameFull: Young BE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 11
              Text: 2024 Nov 14
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2518
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 25
          Titles:
            – TitleFull: Vaccine
              Type: main
ResultId 1